SCHEMBL6949216

SCHEMBL6949216

CS(=O)(=O)c1nc(N)c(C#N)c(N2CCc3ccccc3CC2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.47
ALDH1A1 P00352 8/20 0.47
HPGD P15428 7/20 0.47
KMT2A Q03164 7/20 0.47
MAPT P10636 6/20 0.47
MEN1 O00255 6/20 0.47
HSD17B10 Q99714 4/20 0.47
HTT P42858 3/20 0.47
TP53 P04637 1/20 0.47
ADORA2A P29274 3/20 0.44
RXFP1 Q9HBX9 2/20 0.44
ADRA2A P08913 1/20 0.44
PKM P14618 3/20 0.43
MAPK1 P28482 3/20 0.43
USP2 O75604 2/20 0.43
GAA P10253 1/20 0.43
NPSR1 Q6W5P4 2/20 0.40
POLB P06746 1/20 0.40
RAB9A P51151 1/20 0.40
MAPKAPK2 P49137 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6952384 0.86 ALDH1A1 (0.40) KDM4EALDH1A1HPGDKMT2AMAPT
SCHEMBL6957568 0.81 KDM4E (0.51) KDM4EALDH1A1HPGDKMT2AMAPT
SCHEMBL6957239 0.79 PIK3CD (0.40) KDM4EALDH1A1HPGDKMT2AMAPT
SCHEMBL6948665 0.78 KDM4E (0.48) KDM4EALDH1A1HPGDKMT2AMAPT
SCHEMBL6429843 0.78 KDM4E (0.38) KDM4EALDH1A1HPGDKMT2AMAPT
SCHEMBL6949616 0.74 CCNA2 (0.45) KDM4EALDH1A1HPGDKMT2AMAPT
SCHEMBL6948400 0.72 XDH (0.51) KDM4EALDH1A1HPGDKMT2AMAPT
SCHEMBL6953112 0.72 HPGD (0.44) KDM4EALDH1A1HPGDKMT2AMAPT
SCHEMBL6949441 0.71 ALDH1A1 (0.44) KDM4EALDH1A1HPGDKMT2AMAPT
SCHEMBL6951651 0.71 HPGD (0.43) KDM4EALDH1A1HPGDKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed